2020年美国择期住院全关节置换术病例量:COVID-19大流行的影响
该研究利用Premier医疗数据库和全国住院患者样本,估算2020年美国择期住院全髋和全膝关节置换术病例量。2017至2019年每年约1,006,000例,2020年降至约526,000至538,000例,较前3年平均下降46.5%至47.7%;2020年4月病例量仅为2017至2019年同月平均的1.9%,12月仅为41.0%。
要点
- 2020年美国择期住院全关节置换术估计为526,000至538,000例,较2017至2019年年均1,006,000例下降46.5%至47.7%。
- 2020年4月择期全关节置换术病例量为2017至2019年同月平均的1.9%。
- 2020年12月择期全关节置换术病例量仅为2017至2019年同月平均的41.0%。
核心结论
- 2020年COVID-19大流行期间,美国择期住院全关节置换术病例量约为526,000至538,000例,较前3年下降46.5%至47.7%。
- COVID-19大流行的影响持续至2020年底,病例量至2020年12月仍下降。
研究设计与样本
- 利用Premier医疗数据库识别2017年1月至2020年12月接受初次择期全髋或全膝关节置换术的成人,并交叉参考全国住院患者样本以提供全国代表性抽样权重。
- 排除接受翻修全关节置换术或非择期手术的患者,基于两个数据库建立两个定量模型估算2020年全关节置换术病例量。
- 采用描述性统计报告2020年全年择期全关节置换术利用的月度变化,并进行单变量分析比较亚组间差异。
主要发现
- 2017至2019年,估计每年进行1,006,000例择期住院全关节置换术(64.2%为全膝关节置换术,35.8%为全髋关节置换术)。
- 2020年估计进行526,000至538,000例(62.0%为全膝关节置换术,38.0%为全髋关节置换术),较前3年平均下降46.5%至47.7%。
- 2020年4月择期全关节置换术病例量为2017至2019年同月平均的1.9%。
- 2020年5月和6月病例量较2017至2019年同月增加,随后7月病例量下降,与COVID-19「第二波」对应,之后至12月每月持续下降,与「第三波」对应。
- 2020年12月择期全关节置换术病例量仅为2017至2019年同月平均病例量的41.0%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite known surgical volume reductions in 2020 during the height of the COVID-19 pandemic, no study has fully quantified the impact of the pandemic on the number of elective inpatient total hip (THA) and total knee arthroplasty (TKA) cases. The purpose of the present study was to analyze THA and TKA case volumes in the United States during the COVID-19 pandemic. METHODS: The Premier Healthcare Database was utilized to identify adults undergoing primary elective THA or TKA from January 2017 to December 2020. The National Inpatient Sample was cross-referenced to provide nationwide representative sampling weights. Patients undergoing revision total joint arthroplasty (TJA) or non-elective surgery were excluded. Two quantitative models were created from both databases to estimate TJA case volume in 2020. Descriptive statistics were utilized to report monthly changes in elective TJA utilization throughout 2020. Univariate analyses were performed to compare differences between subgroups. RESULTS: From 2017 to 2019, it was estimated that 1,006,000 elective inpatient TJAs (64.2% TKA and 35.8% THA) were performed annually. In 2020, an estimated 526,000 to 538,000 cases (62.0% TKA and 38.0% THA) were performed, representing a 46.5% to 47.7% decrease in nationwide volume from the prior 3-year average. Moreover, the elective TJA case volume for April 2020 was 1.9% of the average for that month from 2017 through 2019. Subsequently, case volumes for May and June increased compared with the volumes for those months from 2017 through 2019. There was then a decrease in cases for July, corresponding with the "second wave" of COVID-19, followed by an additional steady monthly decline through December, corresponding with the "third wave." Finally, the elective TJA cases for December 2020 represented only 41.0% of the average case volume for that month from 2017 through 2019. CONCLUSIONS: In the midst of the 2020 COVID-19 pandemic, approximately 526,000 to 538,000 elective inpatient TJA cases were performed, representing a 46.5% to 47.7% decrease compared with the 3 previous years. The effects of the COVID-19 pandemic persisted through the end of that year, with decreased case volume through December 2020.
引用
- Heckmann ND, Bouz GJ, Piple AS, et al. Elective Inpatient Total Joint Arthroplasty Case Volume in the United States in 2020: Effects of the COVID-19 Pandemic. J Bone Joint Surg Am. 2022. PMID: 35275853. doi:10.2106/JBJS.21.00833
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。